Pharmaceutical Research and Development Increasing Efficiency through Information Technology and Externalization

GBI Research's pharma report, "PharmaceuticalScope
Research and Development (R&D) - IncreasingThe report analyses the key measures adopted to
Efficency Through Information Technology andimprove the R&D efficiency in the pharmaceutical
Externalization" provides key data, information andand biotech industry along with the major challenges
analysis on major pharmaceutical R&D practicesthat have led to a decrease in the R&D
at the global level in order to improve its efficiency andproductivity over the last decade. The scope of the
effectiveness. This pharmaceutical and healthcarereport includes:
report provides comprehensive insight into the major- Major challenges in the current pharmaceutical
challenges in the current pharmaceutical R&DR&D landscape.
landscape. It analyzes key measures and practices- Key solutions adopted by the pharmaceutical industry
(mergers and acquisitions, R&D restructuring,to improve the R&D productivity which include
outsourcing and active lifecycle management) adoptedstrategic mergers and acquisitions, R&D
by the pharmaceutical industry to tackle theserestructuring, outsourcing and active lifecycle
challenges and improve the R&D efficiency. Themanagement.
report substantiates the analysis with various case- More than 25 examples and case studies explaining
studies to study the effect of measureeach solution and its impact on the R&D
post-implementation. The report also provides anproductivity in a short and long term.
analytical insight into the potential solutions that have- Qualitative analysis of the major potential solutions
tremendous potential to improve the futurethat can improve the R&D productivity in the
pharmaceutical and biotech R&D productivity.future.
The pharmaceutical industry has witnessed aReasons to buy
significant decline in R&D productivity over theThe report will enhance your decision making. It will
past few years, which has become a matter ofallow you to:
concern among the key stakeholders in the industry,- Identify the key R&D challenges in the industry
particularly the pharmaceutical companies. While theand its impact on your company's R&D
R&D expenditure of the industry has steadilyproductivity.
increased, the output has been declining. The increase- Understand the three different focus areas of
in the number of late-stage development failures isimproving R&D efficiency and select the one best
costing the pharmaceutical industry dearly. In addition,suited to the company's long term business strategy.
the stringent regulatory mechanisms on the pricing and- Develop more efficient and effective solutions by
reimbursement of approved drugs have added to theidentifying the implementation issues from the case
pressure. Pharmaceutical companies have tried manystudies and examples covered for each solution.
ways to improve the R&D efficiency which- Ensure sustainable R&D growth by identifying
include the acquisitions of small biotechnology andlong term potential solutions to improve R&D
pharmaceutical companies, R&D restructuring,efficiency.
outsourcing and better lifecycle management of their- Create an integrated and agile R&D organization
existing drugs in the market. However, there has beenthrough the understanding of key technologies and
limited success achieved to date.other external partners in improving the R&D
This report is built using data and information sourcedefficiency in future.
from proprietary databases, primary and secondary- Optimize R&D efforts by identifying the key
research and in house analysis by GBI Research'sareas with maximum revenue potential in future.
team of industry experts.